Home ›
Breast Cancer Trials ›
NCT04025164
Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery
The study was designed to investigate whether hypofractionated radiotherapy(HF-RT) is noninferior to conventionally fractionated radiotherapy (CF-RT) in terms of tumor loco-regional control for patients after breast conserving surgery
Trial Details
NCT ID NCT04025164
Phase NA
Sponsor Fudan University
Status RECRUITING
Cancer Type Breast Cancer
Interventions Hypofractionated Radiotherapy Conventional fractionated Radiotherapy
Locations (sample) Guiyang, Guizhou, China|26.58333,106.71667 Suzhou, Jiangsu, China|31.30408,120.59538 Dalian, Liaoning, China|38.91222,121.60222 Shanghai, Shanghai Municipality, China|31.22222,121.45806 Shanghai, Shanghai Municipality, China|31.22222,121.45806
Key Eligibility Criteria
Age18-70 years Imaging examination confirmed single lesion. if the tumor is multiple, it needs to be removed by single quadrantectomy Receive breast conserving surgery with negative margins Axillary lymph nodes treatment: Sentinel lymph node biopsy or level I/II axillary lymph node dissection. If the sentinel lymph node is negative, th…
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →